Fractyl Health (GUTS) Other Non Operating Income (2023 - 2025)
Fractyl Health (GUTS) reported Other Non Operating Income of -$11000.0 for Q4 2025, down 10.0% year-on-year from -$12222.2 in Q4 2024, and down 83.33% quarter-over-quarter from -$6000.0 in Q3 2025.
Fractyl Health (GUTS) has 3 years of Other Non Operating Income data on file, last reported at -$11000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Non Operating Income fell 10.0% year-over-year to -$11000.0; the trailing twelve-month figure through Dec 2025 stood at -$53000.0 (down 12.77% YoY), and the FY2025 full-year result was -$53000.0, down 12.77% from the prior year.
- Other Non Operating Income for Q4 2025 stood at -$11000.0, down from -$6000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $9000.0 in Q1 2023 and bottomed at -$21000.0 in Q1 2025.
- A 3-year average of -$10333.3 and a median of -$10000.0 in 2024 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income tumbled 211.11% in 2024 and soared 33.33% in 2025, its largest moves.
- Tracing GUTS's Other Non Operating Income over 3 years: stood at -$8000.0 in 2023, then dropped by 25.0% to -$10000.0 in 2024, then decreased by 10.0% to -$11000.0 in 2025.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$11000.0, -$6000.0, and -$15000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Jun 30, 2025 | -15,000.00 |
| Mar 31, 2025 | -21,000.00 |
| Dec 31, 2024 | -10,000.00 |
| Sep 30, 2024 | -9,000.00 |
| Jun 30, 2024 | -18,000.00 |
| Mar 31, 2024 | -10,000.00 |
| Dec 31, 2023 | -8,000.00 |
| Sep 30, 2023 | -8,000.00 |
| Jun 30, 2023 | -17,000.00 |
| Mar 31, 2023 | 9,000.00 |